Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
81 /100
CRITICAL RISK
Score updated Oct 13, 2026

ELTX — Elicio Therapeutics, Inc. Dilution Risk Tracker

Track ELTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ELTX — Get alerts when the score changes →

As of October 13, 2026, Elicio Therapeutics, Inc. (ELTX) has a DilutionWatch DilutionScore of 81/100, rated CRITICAL dilution risk. Elicio Therapeutics, Inc. has a market capitalization of $49.41M, 26.28M shares outstanding, 49 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $400.00M, ATM program capacity of $100.00M, 6.19M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
65
📊 Float Risk
60
⚠️ Warrant Exposure
70
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 41%
💰 Capital Raise model 53%
• Under 12 months cash (7mo)
• Active shelf registration ($400M, 810% of market cap)
📜 Warrant Exercise model 40%
• Significant warrants: 24% of shares outstanding
• Elevated warrant risk score (70/100)
📉 Score Deterioration model 15%
• Score already CRITICAL (81/100) — events likely imminent
🔔 Track ELTX — Get forecast alerts →

Market Data

Market Cap$49.41M
Shares Outstanding26.28M
Float13.19M
Cash$23.48M
Debt$9.54M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore81/100DilutionWatch score record
Shares Outstanding26.28MVerified float table or market cache
Public Float13.19MVerified float table or market cache
Market Cap$49.41MMarket data cache
Cash Runway6.7 monthsDilutionWatch score inputs
Shelf Capacity$400.00MSEC-derived dilution fields
ATM Capacity$100.00MSEC-derived dilution fields
Outstanding Warrants6.19MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 424B5 1, 8-K 1, EFFECT 1, S-3/A 2, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 49.0% shares (2026Q1 vs prior)
49 institutional holders · 3.67M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 1.04M shares
#2 Knoll Capital Management, LLC 630.9K shares
#3 SUSQUEHANNA INTERNATIONAL GROUP, LLP 373.8K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.55M
Days to Cover4.1
% of Float11.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2026-03-12
8-K 8K EVENT 2026-03-16
EFFECT EFFECT 2026-03-16
424B5 ATM 2026-03-16
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ELTX Dilution Snapshot

Elicio Therapeutics, Inc. (ELTX) has a DilutionScore of 81/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ELTX's DilutionScore is currently 81/100 (Critical risk), with 3 score changes tracked over 89 days. The score improved from 71/100 (High risk).

Period Score Risk Level Duration
Sep 30 – Oct 13, 202681/100CRITICAL14 days
Aug 22 – Sep 29, 202671/100HIGH39 days
Aug 14 – Aug 21, 202682/100CRITICAL7 days
Jul 16 – Aug 13, 202677/100CRITICAL29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ELTX shares outstanding have increased 10.6% from 17.26M (Mar 2026) to 19.09M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 14, 202619.09M13.19M▲ 3.75%
Mar 17, 202617.26M12.71M▲ 2.41%
Mar 15, 202617.26M12.41M▲ 5.27%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ELTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ELTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ELTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ELTX
ELTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.